Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4529186 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4529371 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4533219 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4526736 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4528370 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4527772 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4527385 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL52701 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL3468496 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL4538390 | 1.00 | TSHR (0.71) | TSHRLMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085139-A | Polyvinylidene fluoride resin, preparation method and application thereof | 万华化学集团股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-116768952-A | Amphiphilic nano assembly based on hydrophobic molecules and oligonucleotide chains, preparation method and application | 武汉科技大学 | 2023-09-19 | — | — | CN | claimed |
| CN-111362867-B | Mobile terminal, shell assembly, electrochromic material and preparation method thereof | 宁波祢若电子科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-111269710-B | Mobile terminal, shell component, electrochromic material and preparation method thereof | 宁波祢若电子科技有限公司 | 2022-05-20 | — | — | CN | claimed |
| WO-2021107870-A1 | ANTIMICROBIAL AGENT, COATING FORMULATION, COMPOSITE SURFACE COATING AND METHODS OF PREPARING THE SAME | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-06-03 | — | — | WO | claimed |
| CN-111362867-A | Mobile terminal, shell assembly, electrochromic material and preparation method thereof | 宁波祢若电子科技有限公司 | 2020-07-03 | — | — | CN | claimed |
| CN-111269710-A | Mobile terminal, shell component, electrochromic material and preparation method thereof | 宁波祢若电子科技有限公司 | 2020-06-12 | — | — | CN | claimed |
| CN-108047369-B | Holographic optical storage polymer and manufacturing method thereof | 电子科技大学 | 2020-01-24 | — | — | CN | claimed |
| EP-4736858-A1 | TETRAORGANOPHOSPHONIUM COMPOUNDS FOR USE IN THE PREVENTION AND TREATMENT OF METABOLIC DISEASES | Institiute of Clinical and Experimental Medicine (CZ) | 2026-05-06 | — | — | EP | disclosed |
| EP-4665737-A1 | PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | disclosed |
| US-20250223597-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CNS TISSUE | ARROWHEAD PHARMACEUTICALS INC (US) | 2025-07-10 | — | — | US | disclosed |
| EP-4540390-A2 | RNAI AGENTS FOR INHIBITING EXPRESSION OF SUPEROXIDE DISMUTASE 1 (SOD1), COMPOSITIONS THEREOF, AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-4539886-A2 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS TO CNS TISSUE | Arrowhead Pharmaceuticals, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-1998020162-A2 | ELECTRODES LINKED VIA CONDUCTIVE OLIGOMERS TO NUCLEIC ACIDS | CLINICAL MICRO SENSORS (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5750213-A | MOLECULAR ORIENTATION | SHARP KABUSHIKI KAISHA (JP) | 1998-05-12 | — | — | US | disclosed |
| WO-1997025339-A1 | COMPOSITION AND METHOD FOR DELIVERY OF NUCLEIC ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1997-07-17 | — | — | WO | disclosed |
| US-4411903-A | 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4311846-A | 4-[(Monosubstituted-alkyl) amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1982-01-19 | — | — | US | disclosed |
| US-4245097-A | 4-[(Monosubstituted-alkyl) amino] benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1981-01-13 | — | — | US | disclosed |